O
AMGN icon

OrbiMed’s Amgen AMGN Stock Holding History

OrbiMed’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-200,000
Closed -$28.1M – 132
2014
Q3 		$28.1M Buy
+200,000
New +$26.1M 0.29% 63

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

OrbiMed's AMGN Position: Q2 2026 in Review

OrbiMed sold out of Amgen (AMGN) in Q2 2026, closing a stake of 39,900 shares — an estimated $14M sold.

OrbiMed first reported a position in AMGN in Q2 2013 and held it in 46 quarters. The position peaked at $487M in Q1 2015. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • OrbiMed reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • OrbiMed sold 39,900 Amgen shares in Q2 2026, an estimated $14M.
  • OrbiMed first reported a position in Amgen in Q2 2013 and held it in 46 quarters.
  • OrbiMed's Amgen position peaked at $487M in Q1 2015.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.